• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 10/3/24: Data Collection Complexities, 8 Things You May Not Know About Breast Cancer & more

News
Article

The latest news for pharma industry insiders.

Complexities in Data Collection

In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara highlights challenges with data volume and complexity.

8 Things You May Not Know About Breast Cancer

With this year's Breast Cancer Awareness Month now underway, we are sharing eight facts and updates about breast cancer that you might not know about.

Cerebras, an A.I. Chipmaker Trying to Take On Nvidia, Files for an I.P.O.

The Silicon Valley company would be among the first A.I. companies to go public since the release of ChatGPT nearly two years ago.

UnitedHealthcare 2025 Medicare Advantage Plans Deliver Choice, Stability

UnitedHealthcare® has introduced its 2025 Medicare Advantage plans, featuring more choice, broad access to care and stability in the most popular benefits to meet the evolving and varied needs of Medicare consumers.

Jan van de Winkel, Ph.D. on LinkedIn

I'm honored to be featured on the cover of Pharmaceutical Executive! It's incredible to see Genmab and our vision showcased in such a prominent way. This recognition reflects the amazing work of our entire team and the innovation ecosystem that drives us forward. Together, we're committed to delivering innovative and differentiated antibody medicines to patients and advancing the science that can potentially shape the future of healthcare.

A huge thank you to everyone who has supported us on this journey.

#Teamwork #Innovation #AntibodyScience #Biotech

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs